Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | GAA | P10253 | 1/20 | 0.65 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.65 |
| ▸ | PKM | P14618 | 1/20 | 0.65 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.65 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | PPARG | P37231 | 2/20 | 0.50 |
| ▸ | PPARA | Q07869 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | MAP4K4 | O95819 | 2/20 | 0.48 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.46 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.46 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28584562 | 1.00 | CYP1A2 (0.65) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL11749709 | 0.94 | CYP1A2 (0.59) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL47295 | 0.91 | CYP1A2 (0.56) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL4262556 | 0.89 | CYP1A2 (0.77) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL11519440 | 0.84 | CYP1A2 (0.65) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL31147135 | 0.84 | PARP10 (0.48) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL15652500 | 0.84 | PARP10 (0.48) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL21881038 | 0.84 | ALDH1A1 (0.46) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL8900988 | 0.83 | CYP1A2 (0.69) | CYP1A2GAACYP2C9PKMCYP2C19 | |
| SCHEMBL11550164 | 0.83 | CYP1A2 (0.69) | CYP1A2GAACYP2C9PKMCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112062671-B | Preparation method of R- (+) -2- (4-hydroxyphenoxy) propionic acid | 苏州开元民生科技股份有限公司 | 2021-02-09 | — | — | CN | claimed |
| CN-112062671-A | Preparation method of R- (+) -2- (4-hydroxyphenoxy) propionic acid | 苏州开元民生科技股份有限公司 | 2020-12-11 | — | — | CN | claimed |
| US-11007193-B2 | 2,4-pyrimidinediamine compounds and their uses | RIGEL PHARMACEUTICALS, INC. (US) | 2021-05-18 | — | — | US | disclosed |
| CN-112062671-B | Preparation method of R- (+) -2- (4-hydroxyphenoxy) propionic acid | 苏州开元民生科技股份有限公司 | 2021-02-09 | — | — | CN | disclosed |
| CN-112062671-B | Preparation method of R- (+) -2- (4-hydroxyphenoxy) propionic acid | 苏州开元民生科技股份有限公司 | 2021-02-09 | — | — | CN | disclosed |
| CN-112062671-A | Preparation method of R- (+) -2- (4-hydroxyphenoxy) propionic acid | 苏州开元民生科技股份有限公司 | 2020-12-11 | — | — | CN | disclosed |
| CN-112062671-A | Preparation method of R- (+) -2- (4-hydroxyphenoxy) propionic acid | 苏州开元民生科技股份有限公司 | 2020-12-11 | — | — | CN | disclosed |
| US-10828301-B2 | 2,4-pyrimidinediamine compounds and their uses | Rigel Pharmceuticals, Inc. (US) | 2020-11-10 | — | — | US | disclosed |
| US-10709703-B2 | 2,4-pyrimidinediamine compounds and their uses | RIGEL PHARMACEUTICALS, INC. (US) | 2020-07-14 | — | — | US | disclosed |
| US-10682350-B2 | 2,4-pyrimidinediamine compounds and their uses | RIGEL PHARMACEUTICALS, INC. (US) | 2020-06-16 | — | — | US | disclosed |
| US-20200085820-A1 | 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES | RIGEL PHARMACEUTICALS, INC. (US) | 2020-03-19 | — | — | US | disclosed |
| EP-0211326-B1 | PRODUCTION OF GRAVURE INKS FOR ILLUSTRATIONS | BAYER AG (DE) | 1990-06-06 | — | — | EP | disclosed |
| US-4883901-A | Synthesis of 2-(4-aminophenoxy)alkanoic acids and esters and their derivatives | HOECHST CELANESE CORPORATION (US) | 1989-11-28 | — | — | US | disclosed |
| EP-0334598-A2 | Synthesis of 2-(4'aminophenoxy) alkanoic acids and esters and their derivatives | HOECHST CELANESE CORPORATION (US) | 1989-09-27 | — | — | EP | disclosed |
| US-4739042-A | ESTERIFICATION OF AN HYDROXY PYRIDONE DYESTUFF WITH CARBOXYLIC PYRIDINE DYESTUFF | BAYER AKTIENGESELLSCHAFT (DE) | 1988-04-19 | — | — | US | disclosed |
| EP-0211325-A2 | Method of making heliographic and flexographic printing inks | BAYER AG (DE) | 1987-02-25 | — | — | EP | disclosed |
| EP-0211326-A2 | Production of gravure inks for illustrations | BAYER AG (DE) | 1987-02-25 | — | — | EP | disclosed |
| US-4053626-A | CHOLESTEROL LEVEL-LOWERING PHENOXYACETIC ACIDS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1977-10-11 | — | — | US | disclosed |
| US-4026896-A | ANTIALLERGENS | KISSEI YAKUHIN KOGYO KABUSHIKI KAISHA (KISSEI PHARMACEUTICAL CO. LTD.) (JA) | 1977-05-31 | — | — | US | disclosed |
| US-3992386-A | 4(Quinolyl)phenoxy alkanoic acid derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1976-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200085820-A1 | 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES | FCER2, FCGR1A, FCGR2A | CYP1A2 2143/4885GAA 2220/4885CYP2C9 3298/4885 |
| US-10682350-B2 | 2,4-pyrimidinediamine compounds and their uses | FCER2, FCGR1A, FCGR2A | CYP1A2 2143/4885GAA 2220/4885CYP2C9 3298/4885 |
| US-10709703-B2 | 2,4-pyrimidinediamine compounds and their uses | FCER2, FCGR1A, FCGR2A | CYP1A2 2143/4885GAA 2220/4885CYP2C9 3298/4885 |
| US-11007193-B2 | 2,4-pyrimidinediamine compounds and their uses | FCER2, FCGR1A, FCGR2A | CYP1A2 2143/4885GAA 2220/4885CYP2C9 3298/4885 |
| US-10828301-B2 | 2,4-pyrimidinediamine compounds and their uses | FCER2, FCGR1A, FCGR2A | CYP1A2 2143/4885GAA 2220/4885CYP2C9 3298/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.